3 Cash Flow Stocks Worth Watching In Enterprise Software

With inflation trends mixed, bond yields moving in different directions across regions, and energy prices influenced by supply tensions, investors are paying closer attention to what really underpins a stock: its cash generation. The Undervalued Stocks Based On Cash Flows screener focuses on companies where discounted cash flow estimates from SWS suggest the share price does not fully reflect their cash flow potential. For readers looking for ideas grounded in fundamentals rather than headlines, this article highlights 3 stocks from that screener and explains why their cash flow profiles may appeal to value oriented investors right now.

Advertisement

TTM Technologies (TTMI)

Overview: TTM Technologies is a US based electronics manufacturer that builds high end printed circuit boards, RF components, and complete mission systems for customers in aerospace and defense, data centers, automotive, medical, industrial, and networking markets.

Operations: TTM generates most of its roughly US$3.1b in annual revenue from Commercial customers at about US$1.7b and Aerospace & Defense at about US$1.3b, with sales concentrated in the United States at about US$1.6b and other international markets contributing about US$1.2b.

Market Cap: US$14.9b

Investors watching cash generation may find TTM Technologies worth a closer look as it sits at the crossroads of AI data center buildouts and long term US and NATO defense spending, backed by an A&D backlog of US$1.46b and new Ultra HDI and RF capacity in the US and Malaysia. Recent earnings growth, margin improvement and new credit facilities indicate the company has room to fund expansions and acquisitions. However, there are ongoing questions around higher cost US plants, customer concentration, and exposure to US China tensions. The way those risks are managed, alongside the company’s focus on higher value engineered solutions and demand in defense and AI infrastructure, appears central to the investment case investors are currently debating.

TTM Technologies’ cash fueled expansion into defense and AI infrastructure looks like only half the story right now, especially given its A&D backlog and new capacity. To see how those projects, margins and financing terms really fit together, review the analysis report for TTM Technologies

TTMI Discounted Cash Flow as at Jul 2026
TTMI Discounted Cash Flow as at Jul 2026

Cellebrite DI (CLBT)

Overview: Cellebrite DI provides software for law enforcement agencies, governments and corporations to collect, decrypt, analyze and manage digital evidence from phones, computers, cloud services and other devices when carrying out legally sanctioned investigations into crimes such as child exploitation, fraud, terrorism and financial crime.

Operations: Cellebrite generates about US$496.4m in revenue from Internet Software & Services, reflecting its focus on subscription based digital forensics and investigation platforms.

Market Cap: US$3.9b

Cellebrite DI operates at the intersection of rising digital crime, growing data volumes and stricter privacy rules. This combination is encouraging agencies to adopt its SaaS investigation tools, FedRAMP High certified government cloud and AI offerings such as Genesis and Pathfinder. A high share of recurring subscription revenue and a share price below Simply Wall St’s cash flow based fair value estimate make the stock a point of interest for investors focused on fundamentals. At the same time, reliance on US federal contracts, a relatively high P/E multiple and funding that leans on external borrowing mean that execution on international, private sector and AI related expansion will be important in assessing the current valuation.

Cellebrite DI’s recurring SaaS revenue and cash flow focus could be masking a sharper story around contracts, AI tools and valuation. Get the full picture in the 3 key rewards and 1 important warning sign

CLBT Discounted Cash Flow as at Jul 2026
CLBT Discounted Cash Flow as at Jul 2026

Everpure (P)

Overview: Everpure is a US based data storage company that sells all flash arrays, unstructured data systems and subscription software that help enterprises store, protect and move data across on premises and public cloud environments, including AI and Kubernetes workloads.

Operations: Everpure generates about US$3.94b in revenue from Computer Storage Devices, with roughly US$2.67b from the United States and US$1.26b from the rest of the world.

Market Cap: US$23.52b

Everpure attracts attention because it sits where AI infrastructure, data growth and cash generation intersect, with all flash hardware, Purity software and Evergreen subscriptions tied to enterprise and AI workloads. Earnings grew 77.4% over the past year and net margins improved to 5.7%. Simply Wall St’s cash flow model suggests the stock trades below estimated fair value and analyst targets remain more than 20% above the current price. At the same time, a very high P/E multiple, significant insider selling and reliance on external borrowing add risk if growth or AI adoption disappoints. Recent news around AI focused product launches and an activist stake from Jana Partners indicates that the story may still be evolving for Everpure investors.

Everpure’s earnings jump, AI tied products and activist interest suggest the story could be accelerating, but the high P/E, insider selling and borrowing raise sharper questions that the analysis report for Everpure explores in more detail.

P Discounted Cash Flow as at Jul 2026
P Discounted Cash Flow as at Jul 2026

The three stocks in this article are only a starting point, with the full Undervalued Stocks Based On Cash Flows screener uncovering 729 more companies where discounted cash flow estimates suggest similarly compelling stories. If you want to identify the highest conviction setups around cash generation, valuation gaps and real world catalysts, use Simply Wall St to analyze and filter the full Undervalued Stocks Based On Cash Flows screener.

Take Control of Your Investment Journey

If Cellebrite DI or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

New breakouts, fresh momentum and stocks still under the radar for now do not stay quiet for long. Scan these ideas before the crowd and consider your options.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:CLBT

Cellebrite DI

Develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Flawless balance sheet with reasonable growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1156.7% undervalued
52 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4852.5% undervalued
205 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43043.1% undervalued
9 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9954.8% undervalued
13 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

ON
LOT logo
Ontological on Lotus Technology ·

Lotus Tech, Finloop and FOMO Pay Collaborate to Explore Vehicle Tokenization

Fair Value:US$2.463.7% undervalued
1 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
NE
AIIO logo
newsfinder11221 on Robo.ai ·

Robo.ai (NASDAQ: AIIO): Building the Infrastructure Behind the AI Revolution

Fair Value:US$539.0% undervalued
1 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative
EU
European_Hidden_Gem_Stocks
ALMIN logo
European_Hidden_Gem_Stocks on MINT Société anonyme ·

Mint SA: A French Micro-Cap Energy Retailer Worth Watching

Fair Value:€1153.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.916.3% undervalued
89 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.6% undervalued
200 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6510.3% undervalued
73 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0